Drug Survival Outcomes Associated with the Real-World Use of Ixekizumab, Secukinumab, Guselkumab, and Adalimumab for the Treatment of Plaque Psoriasis in China: A 52-Week Single-Center Retrospective Study

• Main Authors: Li Y (Author), Lu JJ (Author), Zhong XY (Author), Yu YY (Author), Yu N (Author), Wang Y (Author), Yi XM (Author), Ding YF (Author), Shi YL (Author)
• Format: Book
• Published: Dove Medical Press, 2022-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Ying Li1,2 *, Jia-Jing Lu1,2 *, Xiao-Yuan Zhong1,2 *, Ying-Yuan Yu1,2 *, Ning Yu,1,2 Yu Wang,1,2 Xue-Mei Yi,1,2 Yang-Feng Ding,1,2 Yu-Ling Shi1,2 1Department of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, People's...